Polymyxin B


Thông tin thuốc gốc
Chỉ định và Liều dùng
Intramuscular
Susceptible infections
Adult: 25,000-30,000 U/kg daily in divided doses 4-6 hrly. Max: 2,000,000 U/day.
Child: <2 yr 40,000 U/kg daily in divided doses 6 hrly (not routinely recommended due to pain at injection sites); ≥2 yr Same as adult dose but not routinely recommended due to pain at injection sites.

Intrathecal
Meningitis
Adult: 50,000 U once daily for 3-4 days, then on alternate days for at least 2 wk after CSF cultures are negative and CSF glucose content is normal. Max: 2,000,000 U/day.
Child: <2 yr 20,000 U once daily for 3-4 days or 25,000 U on alternate days, followed by the latter dose for at least wk after CSF cultures are negative and CSF glucose content is normal; ≥2 yr Same as adult dose.

Intravenous
Susceptible infections
Adult: 15,000-25,000 U/kg daily by continuous IV drip or intermittent infusion 12 hrly at 60-120 min duration. Max: 2,000,000 U/day.
Child: <2 yr 40,000 U/kg daily in divided doses 12 hrly; ≥2 yr Same as adult dose.

Ophthalmic
Ocular infections
Adult: As soln/oint w/ neomycin and dexamethasone: Soln: Instill 1-2 drops into affected eye up to 6 times daily, may be used hrly in severe cases. Oint: Apply a small amount into the conjunctival sac(s) up to 3-4 times daily.
Child: Same as adult dose.

Otic/Aural
Otic infections
Adult: As otic susp containing 3.5 mg neomycin base, 10,000 U and 10 mg hydrocortisone: Instill 4 drops into the affected ear canal 3-4 times daily for up to 10 days.
Child: As otic susp containing 3.5 mg neomycin base, 10,000 U and 10 mg hydrocortisone: Instill 3 drops into the affected ear canal 3-4 times daily for up to 10 days.

Subconjunctival
Ocular infections
Adult: Up to 100,000 U daily.

Topical/Cutaneous
Skin infections
Adult: As 0.1% soln or oint in combination other drugs: Apply onto affected area 1-3 times daily.
Child: Same as adult dose.
Suy thận
Intramuscular, Intravenous, Intrathecal:
Reduce dose. Max: 15,000 U/kg/day.
Hướng dẫn pha thuốc
Intravenous:
Dissolve 500,000 U in 300-500 mL of D5W for continuous IV drip, or intermittent infusion.
Intramuscular:
Dissolve 500,000 U in 2 mL sterile water for inj or NaCl 0.9% inj or 1% procaine HCl inj.
Intrathecal:
Dissolve 500,000 U in 10 mL NaCl 0.9% inj for 50,000 U/mL dosage unit.
Subconjunctival:
Dissolve 500,000 U in 20-50 mL sterile water for inj or NaCl 0.9% inj for a 10,000-25,000 U/mL concentration.
Tương kỵ
Cloxacillin.
Chống chỉ định
Hypersensitivity to polymyxins; perforated ear drums (otic). Concurrent use w/ nephrotoxic and/or neurotoxic drugs and neuromuscular blockers.
Thận trọng
Patients w/ pre-existing nitrogen retention. Renal impairment. Pregnancy and lactation.
Tác dụng không mong muốn
Facial flushing, fever, rash, pruritus, urticaria, skin exanthema, eosinophilia, dizziness, ataxia; severe pain at inj sites (IM), thrombophlebitis (IV) at inj sites. Ophth: ocular discomfort, keratitis, eye irritation.
Potentially Fatal: Nephrotoxicity, neurotoxicity (higher doses or in patients w/ renal impairment); resp paralysis, anaphylaxis, Clostridium difficile-associated diarrhoea and pseudomembranous colitis.
Ophth/Otic/Topical: C (FDA Pregnancy Category C applies to polymyxin B in combination w/ other drugs.)
Thông tin tư vấn bệnh nhân
Eye drop/oint may cause temporary blurred vision or other visual disturbances which may affect ability to drive or operate machinery.
Chỉ số theo dõi
Monitor renal function; neurologic symptoms; signs of superinfection.
Tương tác
Potentially Fatal: Additive neurotoxic or nephrotoxic effect w/ bacitracin, streptomycin, neomycin, kanamycin, gentamicin, tobramycin, amikacin, cephaloridine, paromomycin, viomycin, colistin. Increased risk of resp paralysis w/ neuromuscular blockers (e.g. anaesthetics, muscle relaxants).
Tác dụng
Description:
Mechanism of Action: Polymyxin B disrupts the bacterial cytoplasmic membrane of mostly gm-ve organisms allowing leakage of intracellular constituents by binding to membrane phospholipids.
Pharmacokinetics:
Absorption: Minimal from the GI tract except in infants (≤10% of a dose). Time to peak plasma concentration: W/in 2 hr (IM).
Distribution: Widely distributed; extensively bound to cell membranes in the tissues. Plasma protein binding: Low.
Excretion: Via urine (approx 60% as unchanged drug). Half-life: 6 hr.
Đặc tính

Chemical Structure Image
Polymyxin B

Source: National Center for Biotechnology Information. PubChem Database. Polymyxin b, CID=49800004, https://pubchem.ncbi.nlm.nih.gov/compound/Polymyxin-b (accessed on Jan. 21, 2020)

Bảo quản
Powd for inj: Store between 20-25°C. Protect from light. Reconstituted soln: Store between 2-8°C, stable for 72 hr. Do not store in alkaline soln. Ophth soln/oint: Store below 25°C. Otic soln: Store between 15-25°C. Topical soln/oint: Store between 15-25°C.
Phân loại MIMS
Thuốc kháng khuẩn & khử trùng tai / Thuốc kháng khuẩn & khử trùng mắt / Các loại kháng sinh khác / Thuốc kháng sinh dùng tại chỗ
Tài liệu tham khảo
Anon. Polymyxin B. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 16/06/2015.

Bacitracin Zinc, Neomycin Sulfate and Polymyxin Sulfate Ointment. DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 17/06/2015.

Buckingham R (ed). Polymyxin B Sulfate. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 16/09/2015.

McEvoy GK, Snow EK, Miller J et al (eds). Polymyxin B Sulfate. AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 16/06/2015.

Neomycin and Polymyxin B Sulfates and Hydrocortisone Solution. DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 17/06/2015.

Neomycin Sulfate, Polymyxin B sulfate and Gramicidin Solution/Drops. DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 17/06/2015.

Polymyxin B Sulfate Injection, Powder, for Solution. DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 17/06/2015.

Wickersham RM. Polymyxin B Sulfate. Facts and Comparisons [online]. St. Louis, MO. Wolters Kluwer Clinical Drug Information, Inc. https://www.wolterskluwercdi.com/facts-comparisons-online/. Accessed 17/06/2015.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Polymyxin B từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in